🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSOUL trial preliminary data — November 2025 Page 11

SOUL trial preliminary data — November 2025

JenMemphis Sun, Mar 16, 2025 at 2:50 AM 51 replies 2,130 viewsPage 11 of 11
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Apr 14, 2025 at 2:41 PM#51

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

47 20Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 44 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Apr 15, 2025 at 9:53 AM#52

Following on from Dr.ReproEndo — and this may be the naive question:

How long did you give it before you decided it was working?

Last edited: Apr 15, 2025 at 1:53 PM
48 21NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 45 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Apr 16, 2025 at 5:04 AM#53
TrialTracker_MD said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

49 22MaxMetOK, MounjBrad, nick_newbie and 46 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Apr 17, 2025 at 12:15 AM#54
TrialTracker_MD said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.

50 23TomFromTexas, mike.trainer_LA, sarah_nash92 and 47 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Apr 17, 2025 at 7:25 PM#55
TrialTracker_MD said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Bookmarking. The distinction being drawn above is the one nobody else makes.

1 24Dr.BariatricHTX
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register